1
|
28
|
6t52L |
Thrombin in complex with a d-phe-pro-imidazole derivative |
63
|
258
|
6tklH |
Non-cleavable tsetse thrombin inhibitor in complex with human alpha-thrombin |
66
|
258
|
6tkhH |
Tsetse thrombin inhibitor in complex with human alpha-thrombin - orthorhombic form at 7kev |
7
|
36
|
6tklL |
Non-cleavable tsetse thrombin inhibitor in complex with human alpha-thrombin |
61
|
257
|
6tkjH |
Tsetse thrombin inhibitor in complex with human alpha-thrombin - tetragonal form at 7kev |
58
|
257
|
6t8aH |
Thrombin in complex with diphenyl ((4-carbamimidoylphenyl)((s)-1-((r)-3-cyclohexyl 2-((phenylmethyl)sulfonamido)propanoyl)pyrrolidine-2-carboxamido)methyl)phosphonate (mi-492) |
9
|
30
|
6tkiL |
Tsetse thrombin inhibitor in complex with human alpha-thrombin - tetragonal form at 12.7kev |
2
|
30
|
6t3mL |
Thrombin in complex with a d-phe-pro-p-phenol derivative |
56
|
258
|
6t3mH |
Thrombin in complex with a d-phe-pro-p-phenol derivative |
57
|
258
|
6t57H |
Thrombin in complex with a d-phe-pro-n-amidinopiperidine derivative |
3
|
28
|
6t57L |
Thrombin in complex with a d-phe-pro-n-amidinopiperidine derivative |
56
|
257
|
6t54H |
Thrombin in complex with a d-phe-pro-2-bromothiophene derivative |
1
|
28
|
6t53L |
Thrombin in complex with a d-phe-pro-p-benzylamine derivative |
57
|
258
|
6t53H |
Thrombin in complex with a d-phe-pro-p-benzylamine derivative |
57
|
257
|
6t89H |
Thrombin in complex with (s)-n-(tert-butyl)-4-(3-(3-carbamimidoylphenyl)-2-((2',4'-dimethoxy-[1,1'-biphenyl])-3-sulfonamido)propanoyl)piperazine-1-carboxamide (mi-498) |
1
|
28
|
6t89L |
Thrombin in complex with (s)-n-(tert-butyl)-4-(3-(3-carbamimidoylphenyl)-2-((2',4'-dimethoxy-[1,1'-biphenyl])-3-sulfonamido)propanoyl)piperazine-1-carboxamide (mi-498) |
1
|
29
|
6t55L |
Thrombin in complex with methylbenzylamine |
1
|
30
|
6t56L |
Thrombin in complex with benzylamine |
57
|
257
|
6t56H |
Thrombin in complex with benzylamine |
1
|
27
|
6t54L |
Thrombin in complex with a d-phe-pro-2-bromothiophene derivative |
67
|
259
|
6tkgH |
Tsetse thrombin inhibitor in complex with human alpha-thrombin - orthorhombic form at 12kev |
58
|
257
|
6t55H |
Thrombin in complex with methylbenzylamine |
8
|
36
|
6tkgL |
Tsetse thrombin inhibitor in complex with human alpha-thrombin - orthorhombic form at 12kev |
62
|
259
|
6tkiH |
Tsetse thrombin inhibitor in complex with human alpha-thrombin - tetragonal form at 12.7kev |
47
|
256
|
6z8xH |
X-ray structure of the complex between human alpha thrombin and a thrombin binding aptamer variant (tba-3leu), which contains leucyl amide in the side chain of thy3 at n3. |
57
|
258
|
6z8vH |
X-ray structure of the complex between human alpha thrombin and a thrombin binding aptamer variant (tba-3l), which contains 1-beta-d-lactopyranosyl residue in the side chain of thy3 at n3. |
2
|
27
|
6z8wL |
X-ray structure of the complex between human alpha thrombin and a thrombin binding aptamer variant (tba-3g), which contains 1-beta-d-glucopyranosyl residue in the side chain of thy3 at n3. |
2
|
27
|
6z8vL |
X-ray structure of the complex between human alpha thrombin and a thrombin binding aptamer variant (tba-3l), which contains 1-beta-d-lactopyranosyl residue in the side chain of thy3 at n3. |
0
|
26
|
6z8xL |
X-ray structure of the complex between human alpha thrombin and a thrombin binding aptamer variant (tba-3leu), which contains leucyl amide in the side chain of thy3 at n3. |
58
|
257
|
6z8wH |
X-ray structure of the complex between human alpha thrombin and a thrombin binding aptamer variant (tba-3g), which contains 1-beta-d-glucopyranosyl residue in the side chain of thy3 at n3. |
2
|
27
|
6zuuL |
Crystal structure of thrombin in complex with compound30 |
57
|
257
|
6zuuH |
Crystal structure of thrombin in complex with compound30 |
2
|
27
|
6zuhL |
Crystal structure of thrombin in complex with compound17 |
2
|
27
|
6zugL |
Crystal structure of thrombin in complex with compound10 |
1
|
27
|
6zv8L |
Crystal structure of thrombin in complex with compound51 |
58
|
257
|
6zunH |
Crystal structure of thrombin in complex with compound20a |
55
|
257
|
6zugH |
Crystal structure of thrombin in complex with compound10 |
2
|
27
|
6zunL |
Crystal structure of thrombin in complex with compound20a |
56
|
257
|
6zv8H |
Crystal structure of thrombin in complex with compound51 |
58
|
257
|
6zuxH |
Crystal structure of thrombin in complex with compound42a |
58
|
257
|
6zuhH |
Crystal structure of thrombin in complex with compound17 |
56
|
257
|
6zv7H |
Crystal structure of thrombin in complex with compound42b |
57
|
257
|
6zuwH |
Crystal structure of thrombin in complex with compound40 |
1
|
27
|
6zv7L |
Crystal structure of thrombin in complex with compound42b |
2
|
27
|
6zuwL |
Crystal structure of thrombin in complex with compound40 |
1
|
27
|
6zuxL |
Crystal structure of thrombin in complex with compound42a |
59
|
290
|
6v5tE |
Crystal structure of human prethrombin-2 with tryptophans replaced by 5-f-tryptophan |
53
|
257
|
6v64B |
Crystal structure of human thrombin bound to ppack with tryptophans replaced by 5-f-tryptophan |
3
|
29
|
6v64A |
Crystal structure of human thrombin bound to ppack with tryptophans replaced by 5-f-tryptophan |
1
|
28
|
6t4aL |
Thrombin in complex with a d-phe-pro-p-aminopyridine derivative |